SDX 0.00% 7.0¢ sienna cancer diagnostics limited

My view is sales and licensing to expand US market 2017 and move...

  1. 644 Posts.
    lightbulb Created with Sketch. 66
    My view is sales and licensing to expand US market 2017 and move into Europe 2017/18. R&D to commercialise other cancer diagnostics through 2020. Upside $100M market cap 2020 and happy days. I am holding and here for the ride. DYOR
 
watchlist Created with Sketch. Add SDX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.